758 related articles for article (PubMed ID: 19638254)
1. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
[TBL] [Abstract][Full Text] [Related]
2. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
4. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Taylor DM; Cornelius V; Smith L; Young AH
Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
[TBL] [Abstract][Full Text] [Related]
6. Typical and atypical antipsychotics in bipolar depression.
Gao K; Gajwani P; Elhaj O; Calabrese JR
J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Perlis RH
Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
[TBL] [Abstract][Full Text] [Related]
8. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Goikolea JM; Colom F; Torres I; Capapey J; Valentí M; Undurraga J; Grande I; Sanchez-Moreno J; Vieta E
J Affect Disord; 2013 Jan; 144(3):191-8. PubMed ID: 23089129
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for bipolar depression: a systematic review of randomized, controlled trials.
Vieta E; Locklear J; Günther O; Ekman M; Miltenburger C; Chatterton ML; Aström M; Paulsson B
J Clin Psychopharmacol; 2010 Oct; 30(5):579-90. PubMed ID: 20814319
[TBL] [Abstract][Full Text] [Related]
11. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Gao K; Ganocy SJ; Gajwani P; Muzina DJ; Kemp DE; Calabrese JR
J Clin Psychiatry; 2008 Feb; 69(2):302-9. PubMed ID: 18211129
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L
Postgrad Med; 2010 Jul; 122(4):39-48. PubMed ID: 20675970
[TBL] [Abstract][Full Text] [Related]
13. Bipolar depression: a new role for atypical antipsychotics?
Keck PE
Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.
Perlis RH; Welge JA; Vornik LA; Hirschfeld RM; Keck PE
J Clin Psychiatry; 2006 Apr; 67(4):509-16. PubMed ID: 16669715
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
[TBL] [Abstract][Full Text] [Related]
17. The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Keck PE
J Clin Psychiatry; 2005; 66 Suppl 3():5-11. PubMed ID: 15762829
[TBL] [Abstract][Full Text] [Related]
18. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
Erbe S; Gutwinski S; Bschor T
Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of treatments for bipolar depression.
Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ
J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634
[TBL] [Abstract][Full Text] [Related]
20. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
